Chemoinformaics analysis of 2-Octen-1-ol, 3,7-dimethyl-
| Molecular Weight | 156.269 | nRot | 5 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 1 |
| Exact Molecular Weight | 156.151 | nRing | 0 |
| Solubility: LogS | -3.247 | nHRing | 0 |
| Solubility: LogP | 3.155 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 30.8379 |
| nHD | 1 | BPOL | 20.0641 |
| QED | 0.607 |
| Synth | 2.437 |
| Natural Product Likeliness | 2.36 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.003 |
| HIA | 0.004 |
| CACO-2 | -4.171 |
| MDCK | 0.0000277 |
| BBB | 0.998 |
| PPB | 0.724397 |
| VDSS | 1.233 |
| FU | 0.200765 |
| CYP1A2-inh | 0.715 |
| CYP1A2-sub | 0.432 |
| CYP2c19-inh | 0.106 |
| CYP2c19-sub | 0.345 |
| CYP2c9-inh | 0.328 |
| CYP2c9-sub | 0.86 |
| CYP2d6-inh | 0.022 |
| CYP2d6-sub | 0.14 |
| CYP3a4-inh | 0.027 |
| CYP3a4-sub | 0.211 |
| CL | 8.261 |
| T12 | 0.772 |
| hERG | 0.008 |
| Ames | 0.003 |
| ROA | 0.02 |
| SkinSen | 0.946 |
| Carcinogencity | 0.034 |
| EI | 0.986 |
| Respiratory | 0.03 |
| NR-Aromatase | 0.006 |
| Antiviral | No |
| Prediction | 0.92495 |